ICU Medical, Inc.
ICUI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,382 | $2,259 | $2,280 | $1,316 |
| % Growth | 5.4% | -0.9% | 73.2% | – |
| Cost of Goods Sold | $1,557 | $1,519 | $1,582 | $825 |
| Gross Profit | $825 | $740 | $698 | $491 |
| % Margin | 34.6% | 32.8% | 30.6% | 37.3% |
| R&D Expenses | $89 | $85 | $93 | $47 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $639 | $607 | $608 | $303 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $54 | $25 | $39 | $18 |
| Operating Expenses | $782 | $717 | $741 | $368 |
| Operating Income | $43 | $23 | -$43 | $123 |
| % Margin | 1.8% | 1% | -1.9% | 9.4% |
| Other Income/Exp. Net | -$109 | -$101 | -$72 | -$0 |
| Pre-Tax Income | -$66 | -$78 | -$114 | $123 |
| Tax Expense | $52 | -$49 | -$40 | $20 |
| Net Income | -$118 | -$30 | -$74 | $103 |
| % Margin | -4.9% | -1.3% | -3.3% | 7.8% |
| EPS | -4.83 | -1.23 | -3.11 | 4.86 |
| % Growth | -292.7% | 60.5% | -164% | – |
| EPS Diluted | -4.83 | -1.23 | -3.11 | 4.74 |
| Weighted Avg Shares Out | 24 | 24 | 24 | 21 |
| Weighted Avg Shares Out Dil | 24 | 24 | 24 | 22 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | $8 | $4 | $3 |
| Interest Expense | $107 | $103 | $71 | $1 |
| Depreciation & Amortization | $2 | $229 | $235 | $99 |
| EBITDA | $43 | $253 | $192 | $223 |
| % Margin | 1.8% | 11.2% | 8.4% | 17% |